Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dorgan Drug Importation Amendment Has White House In Thorny Position

Executive Summary

An amendment being debated on the Senate floor that would allow consumers to import prescription drugs from other countries creates a particularly thorny situation for the White House: while President Obama was a co-sponsor of the measure when he was still a freshman senator, his support of it now would effectively break the $80 billion deal he brokered with the pharmaceutical industry

You may also be interested in...



FDA Drug Safety Approach To Be Questioned At House Hearing

Principal Deputy Commissioner Joshua Sharfstein is scheduled to go before the House Energy and Commerce Health Subcommittee on March 10.

FDA Drug Safety Approach To Be Questioned At House Hearing

Principal Deputy Commissioner Joshua Sharfstein is scheduled to go before the House Energy and Commerce Health Subcommittee on March 10.

PhRMA Deal Remains Intact As Senate Majority Leaders Vote Against Drug Importation

The $80 billion deal the Rx industry struck as part of health care reform lives to see another day as drug importation fails on the Senate floor.

Topics

UsernamePublicRestriction

Register

OM014079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel